Skin Cancer

>

Latest News

AI-Powered Detection System for Skin Cancers Receives FDA Approval
AI-Powered Detection System for Skin Cancers Receives FDA Approval

February 18th 2024

The first real-time, non-invasive skin cancer evaluation system has received clearance from the FDA.

FDA Approves TIL Therapy for Unresectable or Metastatic Melanoma
FDA Approves TIL Therapy for Unresectable or Metastatic Melanoma

February 16th 2024

Using AI as an Oncology Nurse
Using AI as an Oncology Nurse

January 5th 2024

Oncology Drug Crash Course: Nivolumab Plus Relatlimab (Opdualag)
Oncology Drug Crash Course: Nivolumab Plus Relatlimab (Opdualag)

December 15th 2023

FDA
FDA Approves Adjuvant Nivolumab for Stage IIB/C Melanoma

October 16th 2023

Latest CME Events & Activities

Miami Breast 2024: Affiliated CE Symposia

March 7, 2024 - March 10, 2024

View More

The Latest on Acute Lymphocytic Leukemia

View More

A Focus on Acute Myeloid Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

8th Annual School of Nursing Oncology™

August 10, 2024

Register Now!

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News

© 2024 MJH Life Sciences

All rights reserved.